| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5693770 | The Breast | 2017 | 5 Pages |
Abstract
Seven days of tamoxifen showed a similar relative decrease in Ki67 as that reported for longer courses, was acceptable to women, and could be considered for window of opportunity studies.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Adam L. Cohen, Rachel E. Factor, Kathi Mooney, Mohamed E. Salama, Mark Wade, Victoria Serpico, Emily Ostrander, Edward Nelson, Jane Porretta, Cindy Matsen, Philip Bernard, Ken Boucher, Leigh Neumayer,